CLB icon

Core Laboratories

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 55.6%
Negative

Neutral
Zacks Investment Research
11 days ago
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines?
CLB shows strong international demand, free cash flow generation and a solid financial position, but near-term U.S. land activity challenges and margin pressure could limit growth.
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines?
Positive
Zacks Investment Research
23 days ago
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y
CLB expects revenues to range from $124 million to $130 million and earnings per share to be between 11 cents and 15 cents for the first quarter of 2026.
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y
Neutral
Seeking Alpha
23 days ago
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript
Positive
Zacks Investment Research
24 days ago
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago.
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates
Neutral
Zacks Investment Research
1 month ago
What's in Store for Core Laboratories Stock in Q4 Earnings?
CLB is expected to report higher revenues than the year-ago period's level. However, it is expected to have faced increased costs and expenses.
What's in Store for Core Laboratories Stock in Q4 Earnings?
Positive
Zacks Investment Research
1 month ago
HAL vs. CLB: Which Stock Is the Better Value Option?
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued stocks?
HAL vs. CLB: Which Stock Is the Better Value Option?
Neutral
Zacks Investment Research
1 month ago
Core Laboratories Stock's Stability Makes It a Wise Hold for Now
CLB shows consistent growth, a strong market position and proprietary tech, but faces challenges like cost pressure, international risks and high valuation concerns.
Core Laboratories Stock's Stability Makes It a Wise Hold for Now
Neutral
PRNewsWire
1 month ago
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2025 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m. EST on February 5, 2026.
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
Negative
Zacks Investment Research
2 months ago
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
Positive
Zacks Investment Research
4 months ago
Core Laboratories Q3 Earnings Surpass Estimates, Decline Y/Y
CLB beats Q3 earnings estimates on strong Production Enhancement results. However, earnings dip y/y due to the Reservoir Description segment's weakness.
Core Laboratories Q3 Earnings Surpass Estimates, Decline Y/Y